Akero Therapeutics Inc. Common Stock (AKRO)
About The Company
Akero Therapeutics Inc is a clinical-stage biotechnology company focused on developing and commercializing transformative treatments for serious metabolic diseases with high unmet medical needs. Its focus is nonalcoholic steatohepatitis, or NASH, a disease without any approved therapies. The company’s product candidate efruxifermin is an FGF21 analog with properties that has the potential to address the core processes underlying NASH pathogenesis.
| IPO Year | Sector | Industry |
|---|---|---|
| 2019 | Health Care | Biotechnology: Pharmaceutical Preparations |
Akero Therapeutics Inc. (AKRO) Latest News
Company Contact & Address (AKRO)
| Corporate Headquarters | Phone | Website |
|---|---|---|
| 601 GATEWAY BOULEVARD SUITE 350, SOUTH SAN FRANCISCO, California, 94080, United States |
+1 650 487-6488 | Official AKRO Website |
AKRO Key Executives
Ownership and management information.
Key Data Points*
| Exchange | Not Available | Market Cap | Not Available |
|---|---|---|---|
| Sector | Health Care | P/E Ratio | Not Available |
| Industry | Biotechnology: Pharmaceutical Preparations | Forward P/E 1 Yr. | Not Available |
| 1 Year Target | Not Available | Earnings Per Share (EPS) | Not Available |
| Today’s High/Low | Not Available | Annualized Dividend | Not Available |
| Share Volume | Not Available | Ex Dividend Date | Not Available |
| Average Volume | Not Available | Dividend Pay Date | Not Available |
| Previous Close | Not Available | Current Yield | Not Available |
| 52 Week High/Low | Not Available | Beta | Not Available |
* Information and data may delayed
Officers & Directors @ AKRO
Jobs & Employment at Akero Therapeutics Inc.
| LinkedIn Company Page | https://www.linkedin.com/company/akerotx |
|---|---|
| Official Career & Employment Page | Careers, Jobs, Employment at Akero Therapeutics Inc. (AKRO) |
Related & Similar Stock Symbols
 AFRIWForafric Global PLC Warrants
|
 DLRDigital Realty Trust Inc. Common Stock
|
 MYMDMyMD Pharmaceuticals Inc. Common Stock
|
Friday, August 12, 2022, 4:36 am (EST)
